Live Chat

Novavax live chart

Mga Pangunahing Kaalaman sa Instrumento

Weekly Search
Weekly
Daily
Petsa Isarado Pagbabago Change (%) Buksan High Low

Mga pinakabagong balita

Frances Wang 2025 Feb 24, 16:00

Cava stock price: Cava Group news and forecast

Space.Xia 2025 Feb 24, 16:00

CBOT Grain Futures: Corn Shorts Surge 17,500 Contracts Ahead of USDA Report

Learn how to invest in tech stocks with high growth potential for long-term gains.
Vanessa L 2025 Feb 24, 09:00

How to Invest in Tech Stocks Amid Nvidia Stock Market Cap Swings

NVDA Stocks Shares
Alibaba’s $52B AI investment drives global interest in investing in AI and cloud computing.
Vanessa L 2025 Feb 24, 03:50

Alibaba's $52B AI Investment Reshapes AI Market

Stocks Shares Tech
Space.Xia 2025 Feb 23, 16:00

Will the Federal Reserve Be Trapped? U.S. Stocks May Face a 10% Sell-Off in the Second Half of the Year!

Tommy Yap 2025 Feb 23, 16:00

Morning Note: Zoom Q4 Earnings, Eurozone Inflation & Oil Prices

Morning Note Oil
Tommy Yap 2025 Feb 22, 16:00

Week Ahead: Australia Inflation and US Core PCE Price Index in Focus

Forex Indices
Why did stock market drop today due to Walmart's economic outlook.
Vanessa L 2025 Feb 21, 06:40

Why Did Stock Market Drop Today? Walmart’s Forecast Sparks Economic Concerns

Info

Spread

0.05

Spread (%)

0.6793 %

Leverage

1:10

Interes sa Magdamagang Pagbili

-0.0597 %

Interes sa Magdamagang Pagtinda

-0.0292 %

Currency

USD

Trading Hours

Oras ng Pagsasara

Martes

14:31 - 20:59

Lunes

14:31-20:59

Miyerkules

14:31-20:59

Huwebes

14:31-20:59

Biyernes

14:31-20:59

Analys och statistik

Buksan

---

Nakaraang Pagsara

---

52 Linggo Mataas/Mababa

--- – ---

Market Cap

1279878016

Natitirang Pagbabahagi

160184992

Petsa ng Mga Kita (Susunod)

2019-05-10

Pambayad si dividend

2019-05-10

Araw ng Pag-alis ng Karapatan sa Dividend

Inaasahang Taunang Rate ng Dividend

0

Inaasahang Taunang Dividend Yield

0

EPS

-2.18

Alamin ang Higit Pa Tungkol sa Instrumentong ito

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Mga kaugnay na instrumento

view_all_instruments
Trustpilot
Live Chat